To the content
3 . 2020

Fat-soluble vitamins and immunodeficiency: mechanisms of influence and opportunities for use

Abstract

The role of vitamins in the formation of the immune response, both innate and acquired immunity, is well known. At the same time, deficit of fat-soluble vitamins A, E, D leads to impaired response of the immune system to the infectious invasion and to disorders of immune system functioning.

The aim of this article is to analyze the literature data on the impact of fat-soluble vitamins on the function of the human immune system and the possibilities of their use in patients with immunodeficiency.

Results. Сurrently, there are enough evidences of the successful use of fat-soluble vitamins in secondary immunodeficiencies. Data on the usage of vitamins A, E, D in the treatment of primary immunodeficiencies are few. However, even reducing of antibiotics and other medicines administration in children with primary immunodeficiency indicates the feasibility of their using. The results of scientific studies on the successful use of vitamins D and A in the treatment of allergic diseases, vitamin D in the prevention and improvement of the treatment of autoimmune and oncological diseases indicate the possibility of their use as adjuvant immunomodulatory therapy in children with primary immunodeficiency. Promising may be the use of vitamins A and E, as powerful antioxidants in patients with primary immunodeficiencies with defects in DNA repair processes.

Conclusion. The analysis of the literature data has shown that despite many questions need to be resolved, fat-soluble vitamins A, D, and E, and their analogues can be used in clinical settings to enhance the therapeutic effect in children with immune deficiency.

Keywords:children, primary and secondary immunodeficiencies, vitamins A, E, D

Funding. The study did not have sponsorship.

Conflict of interests. The authors declare no conflict of interests.

For citation: Kinash M.I., Boyarchuk O.R. Fat-soluble vitamins and immunodeficiency: mechanisms of influence and opportunities for use. Voprosy pitaniia [Problems of Nutrition]. 2020; 89 (3): 22-32. DOI: 10.24411/0042-8833-2020-10026 (in Russian)

References

1. Rosenberg I.H. Challenges and opportunities in the translation of the science of vitamins. Am J Clin Nutr. 2007; 85: 325S-7S.

2. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008; 8 (9): 685-98.

3. Marushchak M., Krynytska I., Fedechko M., et al. Effects of the therapy combining calcium and vitamin D3 supplement with calcitonin on bone tissue density in patients with coronary heart disease complicated with chronic heart failure. Pol Med J. 2019; 280: 128-33.

4. Boyarchuk O.R., Dobrovol’skaya L.I., Kinash M.I., et al. Survey assessment of vitamin D and calcium dietary intake in children with somatic pathology. Voprosy pitaniia [Nutrition Issues]. 2019; 88 (5): 53-62. DOI: 10.1038/nri2378. (in Russian)

5. Bikle D. Vitamin D and immune function: understanding common pathways. Curr Osteoporos Rep. 2009; 7: 58-63.

6. Hewison M. Vitamin D and innate and adaptive immunity. Vitam Horm. 2011; 86: 23-62. DOI: 10.1016/B978-0-12-386960-9.00-002-2.

7. Bousfiha A.A., Jeddane L., Ailal F., et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J. Clin Immunol. 2013; 33 (1): 1-7.

8. Boyarchuk O., Lewandowicz-Uszynska A., Kinash M., et al. Physicians’ awareness concerning primary immunodeficiencies in the Ternopil Region of Ukraine. Pediatria Polska (Polish J Paediatr). 2018; 93 (3): 221-8.

9. Tanngye S.G., Al-Herz W., Bousfiha A., et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020; 40 (1); 24-64. URL: https://doi.org/10.1007/s10875-019-00737-x

10. Kinash M.I., Boyarchuk O.R., Hariyan T.V., Dobrovol’skaya L.I.Issues of improving knowledge about primary immunodeficiencies. 29. Voprosy prakticheskoy pediatrii [Problems of Practical Pediatrics]. 2019; 14 (6): 55-62. DOI: 10.20953/1817-7646-2019-6-55. (in Russian)

11. Boyarchuk O., Kinash M., Hariyan T., Bakalyuk T. Evaluation of knowledge about primary immunodeficiencies among postgraduate medical students. Arch Balkan Med Union. 2019; 54 (1): 11-9.

12. Chernyshova L.I., Volokha A.P., Kostyuchenko L.V., et al. Pediatric Immunology. Kyiv : Meditsina, 2013: 720 p. (in Ukrainian)

13. Samsygina G.A., Vyzhlova E.N. Once again about the problems of the concept of «often sick children». Pediatriya [Pediatrics]. 2016; 95 (4): 209-15. (in Russian)

14. Subbarayan A., Colarusso G., Hughes S.M., et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics. 2011; 127: 810-6.

15. Boyarchuk O., Volokha A., Hariyan T., et al. The impact of com- 33. bining educational program with the improving of infrastructure to diagnose on early detection of primary immunodeficiencies in children. Immunol Res. 2019; 67 (4-5): 390-7. DOI: 10.1007/ s12026-019-09103-w.

16. Slatter M.A., Gennery A.R. Clinical immunology review series: an approach to the patient with recurrent infections in childhood. Clin Exp Immunol. 2008; 152 (3): 389-96. DOI: 10.1111/j.1365-2249.2008.03641.x.

17. de Martino M., Ballotti S. The child with recurrent respiratoryinfections: normal or not? Pediatr Allergy Immunol. 2007; 18 (18): 13-8.

18. Boyarchuk O. Allergic manifestations of primary immunodeficiency diseases and its treatment approaches. Asian J Pharm Clin Res. 2018; 11 (11): 83-90.

19. Boyarchuk O., Dmytrash L. Clinical Clinical manifestations in the patients with primary immunodeficiencies: data from One Regional Center. Turk J Immunol. 2019; 7 (3): 113-9.

20. Allen K.J., Koplin J.J., Ponsonby A.L. et al. Vitamin D insufficiency is associated with challenge-proven food allergy in infants. J Allergy Clin Immunol. 2013; 131 (4): 1109-16.

21. Dini C., Bianchi A. The potential role of vitamin D for prevention and treatment of tuberculosis and infectious diseases. Ann Ist Super Sanita. 2012; 48 (3): 319-27.

22. Muehleisen B., Gallo R.L. Vitamin D in allergic disease: shedding light on a complex problem. J Allergy Clin Immunol. 2013; 131 (2): 324-9.

23. Reinholz M., Ruzicka T., Schauber J. Vitamin D and its role in allergic disease. Clin Exp Allergy. 2012; 42 (6): 817-26.

24. Roider E., Ruzicka T., Schauber J. Vitamin D, the cutaneous barrier, antimicrobial peptides and allergies: is there a link? Allergy Asthma Immunol Res. 2013; 5 (3): 119-28.

25. Povoroznyuk V.V., Reznichenko N.A., Maylyan E.A The extraskeletal effects of vitamin D. Bil. Sugloby. Hrebet [Pain. Joints. Spine]. 2014; 13-14 (1-2): 19-25. (in Ukrainian)

26. Povorozniuk V.V., Pludovsky P. Vitamin D deficiency: Epidemiology, diagnosis, prevention and treatment. Kyiv: Zaslavsky Publishing House, 2015: 262 p. (in Ukrainian)

27. Holick M.F. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-81.

28. Camargo C.A., Ganmaa D., Frazier A.L., et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012; 130: e561-7. DOI: 10.1542/ peds.2011-3029.

29. Bergman P., Norlin A.-C., Hansen S., et al. Vitamin D3 supplementation in patients with frequent respiratory tract infections. A randomised and double-blind intervention study. BMJ. 2012; 2 (6): e001663. DOI: 10.1136/bmjopen-2012-001663.

30. Belderbos M.E., Houben M.L., Wilbrink B., et al. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics. 2011; 127 (6): 1513-20.

31. van Etten E., Mathieu C. Immunoregulation by 1,25-dihydroxyvi-tamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005; 97: 93-101.

32. Topol I., Kamyshny A. Study of expression of TLR2, TLR4 and transckription factor NF-kB structures of galt of rats in the conditions of the chronic social stress and modulation of structure of intestinal microflora. Georgian Med News. 2013; 225: 115-22.

33. Koval H.D., Chopyak V.V., Kamyshnyi O.M., Kurpisz M.K. Transcription regulatory factor expression in T-helper cell differentiation pathway in eutopic endometrial tissue samples of women with endometriosis associated with infertility. Cent Eur J Immunol. 2018; 43 (1): 90-6.

34. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelici-din antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D. FASEB J. 2005; 19 (9): 1067-77. DOI: 10.1096/fj.04-3284com.

35. Kryuchko T.O., Tkachenko O.Ya., Vovk Yu. Congenital components of immunity: TOLL-like receptors in normal and pathological conditions. Zdorov’e rebenka [Child Health]. 2010; 6: 42—45. (in Ukrainian)

36. Hertting O., Holm A., Luthje P., Brauner H. Vitamin D Induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One. 2010; 5 (12): e15580. DOI: 10.1371/journal.pone.0015580.

37. Yang D., Biragyn A., Hoover D. M., et al. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Ann Rev Immunol. 2004; 22 (1): 181—215.

38. Backe F., Takiishi T., Korf H., et al. Vitamin D: Modulator of the immune system. Curr Opin Pharmacol. 2010; 10: 482—96.

39. Hibbs A.M., Ross K., Kerns L.A., et al. Effect of vitamin D supplementation on recurrent wheezing in black infants who were born preterm: the D-Wheeze Randomized Clinical Trial. JAMA. 2018; 319 (20): 2086-94.

40. Maltsev S.V., Ryilova N.V. Vitamin D and immunity. Prakticheskaya meditsina [Practical Medicine]. 2015; 86 (1): 114-20. (in Russian)

41. Snopov S.A. The mechanisms of action of vitamin D on the immune system. Meditsinskaya immunologiya [Medical Immunology ]. 2014; 16 (6): 499-530. (in Russian)

42. Beard J.A., Bearden A., Striker R. Vitamin D and the anti-viral state. J Clin Virol. 2011; 50 (3): 194-200.

43. Liu P. T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311: 1770-3.

44. Shirakawa A.K., Nagakubo D., Hieshima K., et al. 1,25-dihydroxyvi-tamin D3 induces CCR10 expression in terminally differentiating human B cells. J Immunol. 2008; 180 (5): 2786-95. PMID: 18292499.

45. Chen S., Sims G.P., Chen X.X., et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007; 179: 1634-47.

46. Cutolo M., Otsa K., Uprus M., et al. Vitamin D in rheumatoid arthritis. Autoimmun Rev. 2007; 7: 59-64.

47. Bergman P., Lindh A.U., Bjorkhem-Bergman L., Lindh J.D. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2013; 8 (6): e65835. DOI: 10.1371/journal.pone.0065835.

48. Kalmarzi R.N., Ahmadi S., Rahehagh R., et al. The effect of vitamin D supplementation on clinical outcomes of asthmatic children with vitamin D insufficiency. Endocr Metab Immune Disord Drug Targets. 2020; 20 (1): 149-55. DOI: 10.2174/1871530319666190426 161809.

49. Cusato J., Genova C., Tomasello C., et al. Influence of vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab. Cancers (Basel). 2019; 11 (1): 125. DOI: 10.3390/can-cers11010125.

50. Pludowski P., Holick M.F., Grant W.B., et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018; 175: 125-35. DOI: 10.1016/j.jsbmb.2017.01.021.

51. Jimenez-Sousa M.A., Martinez I., Medrano L.M., et al. Vitamin D in human immunodeficiency virus infection: influence on immunity and disease. Front Immunol. 2018; 9: 458. DOI: 10.3389/ fimmu.2018.00458.

52. Norlin A.C., Hansen S., Wahren-Borgstrom E., et al. Vitamin D3 supplementation and antibiotic consumption - results from a prospective, observational study at an immune-deficiency unit in Sweden. PLoS One. 2016; 11 (9): e0163451. DOI: 10.1371/ journal. phone. 0163451.

53. Fedonyuk L.Ya., Oleshchuk A.M., Sas L.M., et al. Polyprag-masy: from paediatrics to geriatrics. Voprosy prakticheskoy pediatrii [Problems of Practical Pediatrics]. 2018; 13 (1): 77-82. DOI: 10.20953/1817-7646-2018-1-77-82. (in Russian)

54. Visy B., Szilagyi T., Kohalmi K.V., et al. Analysis of the relationship between vitamin D3 level and disease severity in hereditary angioedema. Orv Hetil. 2019; 160 (25): 987-93. DOI: 10.1556/650.2019.31429.

55. Moise A.R., Noy N., Palczewski K., Blaner W.S. Delivery of retinoid-based therapies to target tissues. Biochemistry. 2007; 46: 4449-58.

56. DAmbrosio D.N., Clugston R.D., Blaner W.S. Vitamin A metabolism: an update. Nutrients. 2011; 3 (1): 63-103.

57. Marushchak M., Maksiv K., Krynytska I. The specific features of free radical oxidation in patients with chronic obstructive pulmonary disease and arterial hypertension. Pol Med J. 2019; 279: 95-8.

58. Ertesvag A., Engedal N., Naderi S., Blomhoff H.K. Retinoic acid stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid receptor-mediated IL-2 secretion. J Immunol. 2002; 169: 5555-63.

59. Rust P., Eichler I., Renner S., Elmadfa I. Long-term oral p-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Ann Nutr Metab. 2000; 44: 30-7.

60. Rogovyk N.V. The role of vitamin A in patients with cystic fibrosis. Zdorov’e rebenka [Child Health]. 2013; 7 (50): 104-6. (in Ukrainian)

61. Balabolkin M.I. The role of protein glycation, oxidative stress in the pathogenesis of vascular complications in diabetes. In: Materials of the Second Russian National Diabetes Congress. Moscow, 2002: 8-16. (in Russian)

62. Kluzhnikov S.O., Gnetneva E.S., Nechayeva N.L. Vitamin A and carotene: expediency of application in pediatric practice. Pediatriya [Pediatrics]. 2007; 86 (6): 117-22. (in Russian)

63. Ross A.C. Vitamin A status: relationship to immunity and the antibody response. Proc Soc Exp Biol Med. 1992; 200: 303-20.

64. Savustyanenko A.V. The effect of vitamins on the function of the immune system, detoxification and life expectancy. Novosti meditsinyi i farmatsii. [News of Medicine and Pharmacy]. 2010; 21 (349): 23-24. (in Russian)

65. Iwata M., Eshima Y., Kagechika H. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol. 2003; 15: 1017-25.

66. Schuster G.U., Kenyon N.J., Stephensen C.B. Vitamin A deficiency decreases and high dietary vitamin A increases disease severity in the mouse model of asthma. J Immunol. 2008; 180: 1834-42.

67. Semba R.D., Ndugwa C., Perry R.T., et al. Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda: a controlled clinical trial. Nutrition. 2005; 21: 25-31.

68. Moriguchi S., Muraga M. Vitamin E and immunity. Vitam Horm. 2000; 59: 305-36.

69. Field C.J., Johnson I.R., Schley P.D. Nutrients and their role in host resistance to infection. J Leukoc Biol. 2002; 71: 16-32.

70. Brigelius-Flohe R., Traber M.G. Vitamin E: function and metabolism. Nutr Res. 1999; 13: 1145-55.

71. Traber M.G. Vitamin E regulatory mechanisms. Annu Rev Nutr. 2007; 27: 347-62.

72. Lee G.Y., Han S.N. The role of vitamin E in immunity. J Nutrients. 2018; 10 (11): 1614. DOI: 10.3390/nu10111614.

73. Moriguchi S., Kobayashi N., Kishino Y. High dietary intakes of vitamin E and cellular immune functions in rats. J Nutr. 1990; 120: 1096-102. doi: 10.1093/jn/120.9.1096.

74. O’Brien T., Thomas D.G., Morel P.C., Rutherfurd-Markwick K.J. Moderate dietary supplementation with vitamin E enhances lymphocyte functionality in the adult cat. Res Vet Sci. 2015; 99: 63-9. DOI: 10.1016/j.rvsc.2015.01.007.

75. Wu D., Han S.N., Meydani M., Meydani S.N. Effect of concomitant consumption of fish oil and vitamin E on T cell mediated function in the elderly: a randomized double-blind trial. J Am Coll Nutr. 2006; 25: 300-6. DOI: 10.1080/07315724.2006.10719539.

76. Pietrucha B., Heropolitanska-Pliszka E., Maciejczyk M., et al. comparison of selected parameters of redox homeostasis in patients with Ataxia-telangiectasia and Nijmegen breakage syndrome. Oxid Med Cell Longev. 2017; 2017: 6745840. DOI: 10.1155/2017/6745840.

77. Canet-Pons J., Schubert R., Duecker R.P., et al. Ataxia telangiectasia alters the ApoB and reelin pathway. Neurogenetics. 2018; 19: 237-55. URL: https://doi.org/10.1007/s10048-018-0557-5.

78. Aslam A., Misbah S.A., Talbot K., Chapel H. Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency. Clin Immunol. 2004; 112 (1): 24-9.

79. Seth A., Sherman K.E. Fatty liver disease in persons with HIV infection. Top Antivir Med. 2019; 27 (2): 75-82.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

SCImago Journal & Country Rank
Scopus CiteScore
CHIEF EDITOR
CHIEF EDITOR
Viktor A. Tutelyan
Full Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor, Scientific Director of the Federal Research Centre of Nutrition, Biotechnology and Food Safety (Moscow, Russia)

Journals of «GEOTAR-Media»